全文获取类型
收费全文 | 1894篇 |
免费 | 53篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 86篇 |
妇产科学 | 33篇 |
基础医学 | 267篇 |
口腔科学 | 75篇 |
临床医学 | 112篇 |
内科学 | 448篇 |
皮肤病学 | 27篇 |
神经病学 | 155篇 |
特种医学 | 30篇 |
外科学 | 173篇 |
综合类 | 6篇 |
预防医学 | 53篇 |
眼科学 | 127篇 |
药学 | 149篇 |
中国医学 | 6篇 |
肿瘤学 | 202篇 |
出版年
2023年 | 9篇 |
2022年 | 18篇 |
2021年 | 32篇 |
2020年 | 14篇 |
2019年 | 20篇 |
2018年 | 22篇 |
2017年 | 19篇 |
2016年 | 17篇 |
2015年 | 22篇 |
2014年 | 40篇 |
2013年 | 74篇 |
2012年 | 90篇 |
2011年 | 123篇 |
2010年 | 56篇 |
2009年 | 70篇 |
2008年 | 106篇 |
2007年 | 120篇 |
2006年 | 116篇 |
2005年 | 91篇 |
2004年 | 104篇 |
2003年 | 99篇 |
2002年 | 108篇 |
2001年 | 24篇 |
2000年 | 23篇 |
1999年 | 25篇 |
1998年 | 36篇 |
1997年 | 38篇 |
1996年 | 36篇 |
1995年 | 23篇 |
1994年 | 22篇 |
1993年 | 25篇 |
1992年 | 31篇 |
1991年 | 25篇 |
1990年 | 22篇 |
1989年 | 30篇 |
1988年 | 32篇 |
1987年 | 31篇 |
1986年 | 26篇 |
1985年 | 23篇 |
1984年 | 11篇 |
1983年 | 15篇 |
1982年 | 11篇 |
1981年 | 6篇 |
1980年 | 9篇 |
1979年 | 9篇 |
1978年 | 13篇 |
1977年 | 7篇 |
1976年 | 7篇 |
1974年 | 6篇 |
1969年 | 5篇 |
排序方式: 共有1959条查询结果,搜索用时 437 毫秒
991.
992.
Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation 总被引:9,自引:0,他引:9
Taketoshi Suehiro Mitsuo Shimada Keiji Kishikawa Tatsuo Shimura Yuji Soejima Tomoharu Yoshizumi Kohji Hashimoto Yasushi Mochida Shinji Hashimoto Yoshihiko Maehara Hiroyuki Kuwano 《Transplant international》2005,18(8):923-928
The most important problem in the living donor adult liver transplantation (LDALT) is a small for size graft. Although a right lobe graft is used in many cases in order to avoid small for size graft, for a donor, the risk has few in left lobe graft. We evaluate the effect of an intraportal infusion treatment to the small for size graft. One hundred and twelve patients who underwent LDALT were studied. The graft weight recipient standard liver volume ratio (GV/SLV) of these patients were 50% or less. We divided the patients into following two groups; infusion group (n = 53) and control group (n = 59). For the infusion group, 16 G double lumen catheter was inserted into portal vein and nafamostat mesilate (protease inhibitor which stabilize coagulofibrinolytic state; 200 mg/day), prostaglandin E(1) (vasodilator and hepatoprotective effect; 500 microg/day) and thromboxane A(2) synthetase inhibitor (vasodilator and anticoagulant effect; 160 mg/day) were administrated continuously for 7 days. Small-for-size graft syndrome was defined as bilirubin >10 mg/dl and ascites >1000 cc on postoperative day (POD) 14. Comparison examination of a background factors and postoperative bilirubin and amount of ascites was carried out. The mean GV/SLV did not have the difference at 39.1% of infusion group, and 38.3% of control group (P = 0.58). By the control group, 15 patients (25.4%) were small-for-size graft syndrome, however, there was only two (3.8%) small-for-size graft syndrome in infusion group (P = 0.04). The bilirubin levels of infusion and control group on 7 and 14 POD were 9.9 and 7.8 vs. 9.5 and 10.5 mg/dl, respectively. The amount of ascites of infusion group on 7 and 14 POD were 870 and 430 cc, respectively. On the contrary, in control group, the amount of ascites on 7 and 14 POD were 1290 and 1070 cc, respectively. Bilirubin levels and the amount of ascites on 7 and 14 POD were lower in the patients with infusion group then those with control group. There were no differences between infusion group and control group in age, sex and Child's classification. The intraportal infusion had an effect in prevention of hyperbilirubinemia and loss in quality of excessive ascites in the patients with small for size graft. This was suggested to be what is depended on the improvement of the microcirculation insufficiency considered one of the causes of small-for-size graft syndrome. 相似文献
993.
Shin-ichiro Katsuda Yuko Fujikura Yuko Horikoshi Akihiro Hazama Tsuyoshi Shimizu Kohji Shirai 《Journal of atherosclerosis and thrombosis》2021,28(6):611
Aim: The mechanism underlying the stiffness of the aorta and iliofemoral artery that is required to maintain blood pressure (BP) is unclear. A new stiffness index of the aorta (aBeta) and iliac-femoral arteries (ifBeta) was defined by applying the cardio-ankle vascular index (CAVI). We compared changes in stiffness of the two arteries in response to reduced BP, due to the non-selective α adrenergic blocker phentolamine and the β 1 adrenergic blocker atenolol, in rabbits. Methods: Pressure waves at the origin (oA) and distal ends of the aorta (dA) and the distal end of the left femoral artery (fA) were recorded simultaneously using three pressure sensors in 25 anesthetized rabbits. Phentolamine (50 µg/kg/min) and atenolol (10 mg/kg/min) were infused for 2 min. The pulse wave velocity (PWV) in each artery was determined; aBeta, ifBeta, and whole Beta (aifBeta) were calculated by the following formula; Beta=2ρ/PP×ln(SBP/DBP)×PWV 2 (ρ: blood density; SBP, SBP, and PP: systolic, diastolic, and pulse pressures, respectively). Results: SBP and DBP at oA, dA, and fA decreased by the administration of phentolamine and atenolol, with and without decreased total peripheral vascular resistance. After phentramine infusion, cardiac output (CO), aBeta, and aifBeta increased, while ifBeta decreased. After infusion of atenolol, CO decreased, while aBeta, ifBeta, and aifBeta remained unchanged. Conclusion: The contradictory reactions of aBeta and ifBeta to phentolamine suggest that the stiffness of the aorta and ilio-femoral artery is regulated separately during decreased BP induced by phentolamine, but not by atenolol. 相似文献
994.
995.
Dynamic activity-induced manganese-dependent contrast magnetic resonance imaging (DAIM MRI). 总被引:4,自引:0,他引:4
Ichio Aoki Chuzo Tanaka Tetsuro Takegami Toshihiko Ebisu Masahiro Umeda Masaki Fukunaga Kohji Fukuda Afonso C Silva Alan P Koretsky Shoji Naruse 《Magnetic resonance in medicine》2002,48(6):927-933
Activity-induced manganese-dependent contrast (AIM) MRI is a hemodynamic-independent functional MRI method that used manganese ion as an MR-detectable contrast agent. In AIM, MnCl(2) is infused intra-arterially after the blood-brain barrier (BBB) is opened with a hyperosmolar agent. Upon functional stimulation of the brain, Mn(2+) accumulates in the active region(s) by entering active cells through voltage-gated Ca(2+) channels, causing local signal increases in T(1)-weighted images. The contrast of AIM MRI depends strongly on the depth of anesthesia, and the low levels used in somatosensory stimulation studies can lead to significant nonspecific accumulation of manganese ion throughout the brain. The purpose of this study was to produce an AIM functional map of somatosensory stimulation, which separates the stimulation-specific signal increase from the nonspecific activation due to light anesthesia. A dynamic AIM (DAIM) paradigm was developed, which used sequential MR scans during MnCl(2) infusion, prior to and following functional stimulation of the brain. Stimulation-specific functional maps were produced using time-course analysis. The new method was tested during glutamate administration and electric stimulation of the rat forepaw. It was shown that DAIM maps are better confined to the specific region of brain activated by somatosensory stimulation as compared to AIM MRI. 相似文献
996.
Blood-brain-barrier Transport of Lipid Microspheres Containing Clinprost,a Prostaglandin I2 Analogue
Toshiya Minagawa Kohji Sakanaka Shin-Ichi Inaba Yoshimichi Sai Ikumi Tamai Toshio Suwa Akira Tsuji 《The Journal of pharmacy and pharmacology》1996,48(10):1016-1022
Because the permeability of the blood-brain barrier to lipid microspheres (LMs) has not hitherto been demonstrated, blood-brain-barrier permeability to LM containing the prostaglandin I2 analogue clinprost has been evaluated for an in-vitro system of primary cultured monolayers of bovine brain capillary endothelial cells (BCECs), by a capillary depletion study in rats and by an in-situ brain perfusion study in normal and 4-vessel-occluded fore brain ischaemic rats. Although energy-dependency was not observed in [3H]clinprost uptake by BCECs, in accordance with results for simple diffusional transport, uptake of [3H]clinprost contained in lipid microspheres (denoted [3H]clinprost(LM)) was significantly inhibited by the endocytosis inhibitor, dansylcadaverine. The transport of LM into BCECs by endocytosis was also confirmed by fluorescence microscopy and flow-cytometric analysis using LM labelled with a fluorescent probe, 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI). The absolute uptake of DiI(LM) by BCECs, measured by HPLC, was, however, almost 1/10 that of [3H]clinprost(LM), results which suggest the superiority of simple diffusion of clinprost over endocytosis of its LM form in the uptake of clinprost(LM) by BCECs. In the capillary-depletion study with rat-brain-perfused [3H]clinprost(LM) from the internal carotid artery, the parenchyma apparent distribution volume was about 45 times larger than that of the capillary, showing that [3H]clinprost(LM) was transported through the blood-brain barrier into the brain. The permeability coefficients of [3H]clinprost and [3H]clinprost(LM) determined by in-situ brain perfusion in normal rats were considerably higher than those of the active metabolite [3H]isocarbacyclin and its LM form. In addition, the Blood-brain-barrier permeabilities to [3H]clinprost, [3H]isocarbacyclin and their LM forms in ischaemic rats were almost identical to those in normal rats. It was concluded that clinprost(LM) was transported through the blood-brain barrier by endocytosis of LM, simple diffusion of clinprost released from LM, and transport of isocarbacyclin generated by hydrolysis of clinprost. The blood-brain-barrier permeability of clinprost(LM) is not reduced in ischaemic conditions, because the simple diffusion of clinprost released from LM contributed mainly to clinprost(LM) transport. 相似文献
997.
Kouki Masuo Kazuhide Kumagai Takayuki Tanaka Kenichi Yamagata Kohji Shimizu Yoshiaki Nishida Toshimi Iimori 《Surgery today》1998,28(10):997-1000
(Received for publication on Apr. 14, 1997; accepted on Jan. 6, 1998) 相似文献
998.
This note presents current state and background of the homepage of Congenital Anomalies, the online version of the official Journal of the Japanese Teratology Society, and also introduce some of the teratology-related web sites, in the hope that the usage of these and the other Internet tools will contribute greatly toward the advancement of teratology studies. Due to the cross-disciplinary concepts and principles in the field of teratology, no single web site can provide exhaustive coverage of teratology. Nevertheless, there is indeed a great deal of useful information for a teratologist available on the Web. Proper usage of the Internet by exchanging and sharing valuable information can yield the mutual understanding and better collaboration, which in turn is indispensable for the overall measures of congenital anomalies. 相似文献
999.
Lysosomal glycogen storage disease with normal acid maltase with early fatal outcome 总被引:1,自引:0,他引:1
Yutaka Morisawa Mikiya Fujieda Nobuyuki Murakami Keishi Naruse Taisuke Okada Hideo Morita Kei Sawada Jun-ichi Miyazaki Takanobu Kurashige Ikuya Nonaka 《Journal of the neurological sciences》1998,160(2):908-179
In a male infant who had cardiomyopathy, generalized muscle weakness and increased serum creatine kinase levels, his muscle biopsy revealed myopathic changes with tiny intracytoplasmic vacuoles containing PAS-positive material and high acid phosphatase activity, but had normal acid maltase activity biochemically. These findings were consistent with those seen in lysosomal glycogen storage disease with normal acid maltase (Danon disease). Sarcolemmal indentations commonly seen in this disease were missing, but a complement membrane attack complex, C5b-9 was positive along the surface membrane of the muscle fibers as seen in X-linked vacuolar myopathy. The patient was on a respirator and died at 27 months of age from pneumonia and hypertrophic cardiomyopathy. Lysosomal glycogen storage disease with normal acid maltase may be manifested at birth with marked skeletal and cardiac involvement leading to death in early infancy. 相似文献
1000.
Neuroprotective effect of postischemic administration of sodium orthovanadate in rats with transient middle cerebral artery occlusion. 总被引:4,自引:0,他引:4
Yu Hasegawa Jun-Ichiro Hamada Motohiro Morioka Shigetoshi Yano Takayuki Kawano Yutaka Kai Kohji Fukunaga Yukitaka Ushio 《Journal of cerebral blood flow and metabolism》2003,23(9):1040-1051
Orthovanadate is a competitive inhibitor of protein tyrosine phosphatases. Some of its reported biologic effects are its insulin mimetic property and its activation of phosphoinositide 3-kinase and extracellular-signal regulated kinase (ERK). The authors previously reported its neuroprotective effect on delayed neuronal death of gerbil hippocampal CA1 neurons via Akt and ERK activation after transient forebrain ischemia. In the present study, the neuroprotective effect of postischemic intraperitoneal administration of sodium orthovanadate (2 l/kg of 50-mmol/l sodium orthovanadate in saline) was investigated in rats with transient middle cerebral artery occlusion. Ischemic neuronal injury was evaluated 1 day and 28 days after ischemia. The neuroprotective effect of orthovanadate was significant in the cortex but not the caudate putamen (ischemic core) at both 1 and 28 days after ischemia. In orthovanadate group, the activities of Akt and ERK were maintained after reperfusion; they were decreased in saline group. Blood glucose level decreased but within normal range. Regional cerebral blood flow was lower than that of saline group only at 0 hours after reperfusion. These data suggest that orthovanadate has neuroprotective effects in rats with transient middle cerebral artery occlusion and that these effects are mediated by Akt and ERK activation. Furthermore, low blood glucose levels and gradual recovery of regional cerebral blood flow may contribute to neuroprotection. 相似文献